Exercise and nutrition for Metabolic Syndrome

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Metabolic Syndrome+1 MoreExercise and nutrition - Behavioral
Eligibility
30 - 70
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test whether Noom, a weight-loss app, helps people with type 2 diabetes better stick to their exercise and diet plan, leading to more weight loss and better health.

Eligible Conditions
  • Metabolic Syndrome
  • Type 2 Diabetes

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: Over the course of 5 months

Month 5
Body Weight
Month 5
Flow-mediated dilation
Glucose Tolerance

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Exercise and Diet Standard of Care
1 of 2
Noom+Exercise and Diet Standard of Care
1 of 2

Active Control

Experimental Treatment

63 Total Participants · 2 Treatment Groups

Primary Treatment: Exercise and nutrition · No Placebo Group · N/A

Noom+Exercise and Diet Standard of CareExperimental Group · 2 Interventions: Exercise and nutrition, Noom mobile application · Intervention Types: Behavioral, Behavioral
Exercise and Diet Standard of Care
Behavioral
ActiveComparator Group · 1 Intervention: Exercise and nutrition · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: over the course of 5 months

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
374 Previous Clinical Trials
58,485 Total Patients Enrolled
1 Trials studying Metabolic Syndrome
80 Patients Enrolled for Metabolic Syndrome
Noom Inc.Industry Sponsor
15 Previous Clinical Trials
2,399 Total Patients Enrolled
Steven K Malin, PhDPrincipal InvestigatorRutgers University - New Brunswick
2 Previous Clinical Trials
160 Total Patients Enrolled
2 Trials studying Metabolic Syndrome
160 Patients Enrolled for Metabolic Syndrome

Eligibility Criteria

Age 30 - 70 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
A person with a body mass index between 28-45 kg/m2 is considered overweight.
A person who was previously diagnosed with T2DM.
People who are currently taking medications that affect heart rate and rhythm, such as calcium channel blockers, nitrates, alpha- or beta-blockers.
People aged 30 to 70 who are male or female.

Who else is applying?

What state do they live in?
New York100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%